Sal Guccione is an Executive Advisor to New Mountain Capital, LLC. He is also Executive Chairman of The Emmes Company, LLC, a clinical stage contract research organization advancing pharmaceutical and public health research. Mr Guccione brings more than 30 years of leadership experience, including CEO, CFO and strategic planning/M&A in the specialty chemicals and pharmaceutical ingredients industries. He was President and Chief Executive Officer of Aceto Corporation until 2017. Prior to that, he was CEO of WIL Research Laboratories. Mr. Guccione was also Executive Vice President, Strategy, Chief Financial Officer and Vice President, Corporate Development of Cambrex Corporation, a leading active pharmaceutical ingredients company and CDMO. Prior to that, he was Vice President, General Manager of ISP Personal Care Ingredients, a global developer, manufacturer and marketer of specialty chemical ingredients for the personal care industry.
Mr. Guccione holds a Bachelor of Science degree in chemical engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business.